(Q53189572)

12 May 2018

title

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. (English)

1 reference

12 May 2018

1 reference

1 reference

metastatic colon cancer

1 reference

1 reference

A Hendlisz

1

1 reference

12 May 2018

V Golfinopoulos

2

1 reference

12 May 2018

C Garcia

3

1 reference

12 May 2018

A Covas

4

1 reference

12 May 2018

P Emonts

5

1 reference

12 May 2018

L Ameye

6

1 reference

12 May 2018

M Paesmans

7

1 reference

12 May 2018

A Deleporte

8

1 reference

12 May 2018

G Machiels

9

1 reference

12 May 2018

E Toussaint

10

1 reference

12 May 2018

B Vanderlinden

11

1 reference

12 May 2018

A Awada

12

1 reference

12 May 2018

M Piccart

13

1 reference

12 May 2018

P Flamen

14

1 reference

12 May 2018

publication date

23 November 2011

1 reference

12 May 2018

published in

Annals of Oncology

1 reference

12 May 2018

volume

23

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

1687-1693

1 reference

12 May 2018

Estimates of the cancer incidence and mortality in Europe in 2006.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Causes and consequences of increased glucose metabolism of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR554

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR554

1 reference

12 May 2018

PubMed ID

22112970

1 reference

12 May 2018